The role of interferon γ in regulation of CD4+ T-cells and its clinical implications

被引：54

作者：

Chen, Jiezhong ^{[1
]}

Liu, Xiaosong ^{[2
]}

机构：

[1] Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia

[2] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4102, Australia

来源：

CELLULAR IMMUNOLOGY | 2009年 / 254卷 / 02期

关键词：

Interferon gamma; Interferon gamma receptor; T-regulatory cells; CD4(+) T-cells; Apoptosis; Autoimmune diseases; Rheumatoid arthritis; Type; 1; diabetes; Multiple sclerosis; COLLAGEN-INDUCED ARTHRITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NONOBESE DIABETIC MICE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NILE-VIRUS-INFECTION; RECEPTOR-BETA CHAIN; IFN-GAMMA; MYCOBACTERIAL INFECTION; ORAL TOLERANCE; NOD MICE;

D O I：

10.1016/j.cellimm.2008.09.001

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Interferon gamma (IFN gamma) plays a central role in the immune response against infection and tumur immune surveillance. Its functions include not only activation of the host immune system to control microbial infections but also repression of autoimmune responses by turning on T-regulatory cells and increasing T effector cell apoptosis. Defects in IFN gamma and IFN gamma receptor genes have been associated with autoimmune diseases such as rheumatoid arthritis, type 1 diabetes and multiple sclerosis. However, treatment of autoimmune diseases by supplementing with IFN gamma has been satisfactory due to its broad biological effects. Instead, its target T-regulatory cells may be used for the clinical treatment of autoimmune diseases. Future study could also focus on promotion of the beneficial effects of IFN gamma and blocking those unwanted IFN gamma-induced activities. (c) 2008 Elsevier Inc. All rights reserved.

引用

页码：85 / 90

页数：6

共 50 条

[31] GM-CSF production by CD4+ T cells in MS patients: Regulation by regulatory T cells and vitamin D
Peelen, E.
Muris, A. -H.
Damoiseaux, J.
Knippenberg, S.
Broens, K.
Smolders, J.
Tervaert, J. W. Cohen
Hupperts, R.
Thewissen, M.
JOURNAL OF NEUROIMMUNOLOGY, 2015, 280 : 36 - 42
[32] Immune regulation of multiple sclerosis by CD8+T cells
Sinha, Sushmita
Itani, Farah R.
Karandikar, Nitin J.
IMMUNOLOGIC RESEARCH, 2014, 59 (1-3) : 254 - 265
[33] Idd9.2 and Idd9.3 Protective Alleles Function in CD4+ T-Cells and Nonlymphoid Cells to Prevent Expansion of Pathogenic Islet-Specific CD8+ T-Cells
Hamilton-Williams, Emma E.
Wong, S. B. Justin
Martinez, Xavier
Rainbow, Daniel B.
Hunter, Kara M.
Wicker, Linda S.
Sherman, Linda A.
DIABETES, 2010, 59 (06) : 1478 - 1486
[34] Induction of CD69 antigen on normal CD4+ and CD8+ lymphocyte subsets and its relationship with the phenotype of responding T-cells
Rutella, S
Rumi, C
Lucia, MB
Barberi, T
Puggioni, PL
Lai, M
Romano, A
Cauda, R
Leone, G
CYTOMETRY, 1999, 38 (03): : 95 - 101
[35] LOSS RATHER THAN DOWN-REGULATION OF CD4+ T-CELLS AS A MECHANISM FOR REMISSION FROM EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
ZEINE, R
OWENS, T
JOURNAL OF NEUROIMMUNOLOGY, 1993, 44 (02) : 193 - 198
[36] Activated CD4+ T cells enhance radiation effect through the cooperation of interferon-γ and TNF-α
Wang, Yixiang
Radfar, Soroosh
Khong, Hung T.
BMC CANCER, 2010, 10
[37] Therapeutic potential of hyporesponsive CD4+ T cells in autoimmunity
Maggi, Jaxaira
Schafer, Carolina
Ubilla-Olguin, Gabriela
Catalan, Diego
Schinnerling, Katina
Aguillon, Juan C.
FRONTIERS IN IMMUNOLOGY, 2015, 6
[38] The Role of Citrullination Modification in CD4+ T Cells in the Pathogenesis of Immune-Related Diseases
Chen, Yuhang
Teng, Yi
Xu, Ping
Wang, Shengjun
BIOMOLECULES, 2024, 14 (04)
[39] The dichotomous outcomes of TNFα signaling in CD4+ T cells
Skartsis, Nikolaos
Ferreira, Leonardo M. R.
Tang, Qizhi
FRONTIERS IN IMMUNOLOGY, 2022, 13
[40] Control of inflammatory heart disease by CD4+ T cells
Barin, Jobert G.
Cihakova, Daniela
YEAR IN IMMUNOLOGY, 2013, 1285 : 80 - 96

← 1 2 3 4 5 →